Panelists discuss how significant gaps in current uncomplicated urinary tract infection (UTI) therapies include insufficient nonantibiotic preventive strategies, limited options for ...

Most of the participants were male (69%), were aged between 45 and 54 years (54%), were working in a group practice (46%) and had their practice located in a rural area or small town (54%). Compared ...

When it comes to UTIs, anatomy is destiny. About half of all women will have at least one UTI in their lifetime. Only about 10% of men will have one.

Panelists discuss how fluoroquinolones are generally reserved for uncomplicated urinary tract infections (UTIs) only when first-line options are contraindicated or pathogen resistance is confirmed, ...

Reports indicate that urinary tract infection (UTI) is the most common bacterial infection, with half of all women experiencing at least one UTI in their lifetime. [1,2] Of these, 25-40% will develop ...

The novel investigational oral antibiotic gepotidacin was efficacious and safe for the treatment of uncomplicated urinary tract infections, with activity against common uropathogens. Gepotidacin, a ...

Despite major changes in the prevalence of antibiotic resistance, the 2011 IDSA guideline for uncomplicated UTI still accurately reflects the efficacy and safety of first-line treatments. New data ...

Gepotidacin is an oral, first-in-class triazaacenaphthylene antibiotic that inhibits bacterial DNA replication by blocking 2 different type II topoisomerase enzymes. Study participants were randomly ...

The FDA approved the first new antibiotic for urinary tract infections in two decades. The approval for Pivya was given to Utility Therapeutics, a U.S. company that acquired the rights to the drug. It ...

UTIs are generally caused by bacteria — E. coli, most often — and research suggests that, at least in some cases, the ...

April 24 (UPI) --The newly approved oral medication Pivya provides women with another option for treating uncomplicated urinary tract infections, the U.S. Food and Drug Administration announced ...

Millions of times a year, Americans seek urgent treatment for painful, embarrassing urinary tract infections. But while they ...